Thursday, January 31, 2013

Calling The Generics Biosimilars














If you want to protect your drug monopoly, impoverish your customers, and help sink U.S. federal health care.....call the generic competition-drugs "biosimilars." After intense lobbying by drug giants, Virginia has already banned "biosimilars."

No comments:

Post a Comment